• Hemant Surgical will hold a board meeting on May 15, 2026 to approve audited standalone and consolidated financial results for H2 and FY ended March 31, 2026.
• The trading window for designated persons has been closed since April 1, 2026 under the company's insider trading code.
• The trading window will reopen 48 hours after the financial results are declared to the stock exchanges.